Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene

Cancer Research

Volumn 56, Issue 7, 1996, Pages 1526-1532

  Kim, Perry M ^a   Wells, Peter G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; PEROXIDASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROTECTION; COMPETITIVE INHIBITION; ENZYME INHIBITION; ENZYME SPECIFICITY; GENOTOXICITY; GLUCURONIDATION; MICRONUCLEUS; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FIBROBLAST; TRANSLATION INITIATION;

ANIMALS; BENZO(A)PYRENE; CARCINOGENS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; GLUCURONOSYLTRANSFERASE; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NITROSAMINES; PEROXIDASES; RATS; RATS, GUNN; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TETRACHLORODIBENZODIOXIN;

EID: 0029863728     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adams, J D , Lee, S J , Vinchkoski, N., Castonguay, A , and Hoffman, D. On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking. Cancer Lett., 17: 339-346, 1983.
2. Hecht, S S., Carmella, S G., Foiles, P G., and Murphy, S E. Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines Cancer Res. (Suppl.), 54. 1912s-1917s, 1994.
3. Hoffman, D., Rivenson, A., Chung, F. L., and Hecht, S. S. Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis Crit Rev. Toxicol., 21: 305-311 1991
4. Osborne, M. R , and Crosby, N T. Benzo[a]pyrene, pp. 198-221. Cambridge: Cambridge University Press, 1987
5. Dutton, G. J. Glucuronidation of Drugs and Other Compounds Boca Raton, FL. CRC Press, 1980.
6. Burchell, B , and Coughtrie, M. W. H. UDP-glucuronosyltransferases. Pharmacol Ther , 43: 261-289, 1989
7. Burchell, B , Nebert, D W , Nelson, D. R., Bock, K. W , Iyanagi, T., Jansen, P L. M., Lancet, D , Mulder, G. J., Roy Chowdhury, J , Siest, G , Tephley, T. R., and Mackenzie, P. I. The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol , 10: 487-494, 1991.
8. de Morais, M. F., and Wells, P G. Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity J. Pharmacol Exp. Ther., 247: 323-331, 1988
9. Hu, Z., and Wells, P G. Human interindividual variation in lymphocyte UDP-glucuronosyltransferases as a determinant of benzo[a]pyrene covalent binding and cytotoxicity. Proc Int. Soc. Study Xenobiot. (ISSX), 4: 31, 1993.
10. Vienneau, D. S., DeBoni, U., and Wells, P. G. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo[a]pyrene and benzo[e]pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts Cancer Res., 55: 1045-1051, 1995.
11. Wells, P. G., Obilio, F. C., and de Morais, S. M. F. Benzo[a]pyrene embryopathy in rats genetically deficient in bilirubin UDP-glucuronosyltransferase. FASEB J., 3: A739, 1989.
12. Moghrabi, N., Sutherland, L., Wooster, R., Povey, S., Boxer, M., and Burchell, B. Chromosomal assignment of human phenol and bilirubin UDP-glucuronosyltransferase gene (UGT1A-subfamily). Ann. Hum. Genet., 56: 81-91, 1992.
13. Monaghan, G., Povey, S., Burchell, B., and Boxer, M. Localisation of bile acid UDP-glucuronosyltransferase gene (UGT2B) to chromosome 4 using the polymerase chain reaction. Genomics, 13: 908-909, 1992.
14. Brierly, C. H., and Burchell, B. Human UDP-glucuronosyl transferases: chemical defence, jaundice and gene therapy. Bioessays, 15: 749-754, 1993.
15. Jansen, P. L. M., Mulder, G. L , Burchell, B., and Bock, K. W. New developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease." Hepatology, 15. 532-544, 1992
16. Odell, G. B., and Childs, B. Hereditary hyperbilirubinemias. In. A. G. Steinberg, A. G. Bearn, A. G. Motusley, and B. Childs (eds.), Progress in Medical Genetics. Vol., 4, pp. 103-134. Philadelphia: W B Saunders, 1980.
17. Bosma, P J., Roy Chowdhury, N., Goldhoorn, B. G , Hofker, M. H., Oude Elferink, R. P. J., Jansen, P. L. M., and Roy Chowdhury, J. Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome type I. Hepatology, 15. 941-947, 1992.
18. Bosma, P. J., Goldhoorn, B., Oude Elferink, R. P. J., Sinaasappel, M., Oostra, B. A., and Jansen, P. L. M. A mutation in bilirubin uridine 5′diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology, 105: 216-220, 1993.
19. Moghrabi, N , Sutherland, L., Wooster, R., Povey, S., Boxer, M., and Burchell, B. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implications in carrier detection and prenatal diagnosis. Am. J. Hum. Genet., 53: 722-729, 1993.
20. Moghrabi, N , Sutherland, L., Wooster, R., Povey, S., Boxer, M., and Burchell, B. Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics, 18: 171-173, 1993.
21. Burchell, B., Coughtrie, M. H., and Jansen, P. L. M. Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease: report of the seventh international workshop on glucuronidation, September 1993, Pitlochry, Scotland. Hepatology, 20: 1622-1630, 1994
22. de Morais, M. F., and Wells, P. G Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency. Hepatology, 10: 163-167, 1989.
23. de Morais, M. F., Chow, S. Y. M., and Wells, P. G. Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. Toxicol. Appl. Pharmacol., 117: 81-87, 1992.
24. de Morais, M. F., Uetrecht, J. P., and Wells, P. G. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology, 102: 577-586, 1992.
25. Hu, Z., and Wells, P. G. In vito and in vivo biotransformation and covalent binding of benzo[a]pyrene in Gunn and RHA rats with genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. J. Pharmacol Exp. Ther , 263: 334-342, 1992.
26. Hu, Z., and Wells, P. G. Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP- glucuronosyltransferases. Toxicol. Appl. Pharmacol., 127. 306-313, 1994
27. Kim, P. M , and Wells, P. G. Mechanism of benzo[a]pyrene (B[a]P)-induced micronucleus formation in cultured skin fibroblasts from Wistar rats. Toxiologist, 14: 223, 1994.
28. Kim, P. M., and Wells, P G. Evidence for cytochrome P450IA1- and prostaglandin H synthase-dependent DNA oxidation in the mechanism of benzo[a]pyrene-initiated micronucleus formation in cultured Wistar rat skin fibroblasts. Proc. Am. Assoc Cancer Res , 36: 600, 1995
29. Crespi, C. L., Penman, B. W., Gelboin, H. V , and Gonzalez, F. J. A tobacco smoke-derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis, 12: 1197-1201, 1991.
30. Guo, Z., Smith, T. J., Thomas, P. E., and Yang, C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys , 298: 279-286, 1992.
31. Smith, T J , Guo, Z., Gonzalez, F. J., Guengerich, F P., Stoner, G. D., and Yang, C S Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res., 52: 1757-1763, 1992.
32. Lacroix, D , Desrochers, M , Castonguay, A., and Anderson, A. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. Carcinogenesis, 14: 1639-1642, 1993.
33. Nesnow, S , Beck, S., Rosenblum, S., Lasley, J., Tiano, H. F., Hosokawa, M., Crespi, C. L., and Langenbach. R. N-nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced morphological transformation of C3H/10T1/2CL8 cells expressing human cytochrome P450 2A6 Mutat. Res., 324. 93-102, 1994.
34. Alaoui-Jamali, M. A., Rossignol, G., Schuller, H. M., and Castonguay, A. Transplacental genotoxicity of a tobacco-specific N-nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in Syrian golden hamster. Mutat. Res., 223: 65-72, 1989.
35. Bilodeau, J., Wang, M., Chung, F., and Castonguay, A. Effects of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice. Free Rad. Biol. Med., 18: 47-54, 1995
36. Ronai, Z. A., Gradia, S., Peterson, L. A , and Hecht, S. S. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis, 14: 2419-2422, 1993.
37. 6-methylguanine and 7-methylguanine, in respiratory and other tissues of rat, mouse and Syrian hamster exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis, 15: 2023-2029, 1994.
38. 6-methylguanine. Cancer Res., 53: 2780-2785, 1993.
39. Liu, Y , Sundqvist, S , Belinsky, S. A., Castonguay, A., Tjalve, H., and Grafstrom, R. C. Metabolism and macromolecular interaction of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in cultured explants and epithelial cells of human buccal mucosa Carcinogenesis, 14: 2383-2388, 1993.
40. Weitberg, A. B., and Corvese, D Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin. Genet., 43: 88-91, 1993.
41. Jorquera, R , Castonguay, A., and Schuller, H. M. DNA single-strand breaks and toxicity induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or N-nitrosdimethylamine in hamster and rat liver Carcinogenesis, 15: 389-394, 1994.
42. Murphy, S. E , Spina, D. A., Nunes, M G., and Pullo, D. A. Glucuronidation of 4((hydroxymethyl)nitrosamino)-1-(3-pyridyl)-1-butanone. a metabolically activated form of 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital-treated rats. Chem. Res. Toxicol., 8: 772-779, 1995
43. Winn, L M., and Wells, P. G Phenytoin-initiated DNA oxidation in murine embryo culture, and embryoprotection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol. Pharmacol., 48: 112-120, 1995.
44. Carmella, S G., Akerkar, S., and Hecht, S. S. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res., 53: 721-724, 1993.
45. Morse, M A , Eklind, K. I , Toussaint, M., Amin, S. G., and Chung, F. L. Characterisation of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis, 11: 1819-1823, 1990.
46. Okey, A. B., Riddick, D. S., and Harper, P. A. The Ah receptor mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett., 70. 1-22, 1994.
47. Owens, I S. Genetic regulation of UDP-glucuronosylrransferase induction by polycyclic aromatic compounds in mice. J. Biol. Chem., 252. 2827-2833, 1977.
48. Roy Chowdhury, J., Huang, T., Kesari, K., Lederstein, M., Arias, I. M., and Roy Chowdhury, N Molecular basis for the lack of bilirubin-specific and 3-methylcholanthrene-inducible UDP-glucuronosyltransferase activities in Gunn rats J. Biol. Chem , 266: 18294-18298, 1991
49. DeBoni, U., Kim, P M., and Wells, P G Induction by 2,3,7.8-tetrachlorodibenzo-p-dioxin (TCDD) of prostaglandin H synthase (PHS) and peroxidase-dependent, benzo[a]pyrene (B[a]P)-initiated protein oxidation in the mechanism of B[a]P genotoxicity. Toxicologist, 16: 1259, 1996.
50. Dinarello, C. A Interleukin-I Adv. Pharmacol., 25: 21-51, 1994
51. Ortiz de Montellano, P. R., and Mathews, J. M. Autocatalytic alkylation of the cytochrome P450 prosthetic haem group by 1-aminobenzotriazole. Biochem. J., 195: 761-764, 1981.
52. Mugford, C. A., Mortillo, M., Mico, B. A , and Tarloff, J B 1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats. Fundam. Appl. Toxicol , 19: 43-49, 1992
53. Marnett, L J , Reed, G. A., and Johnson, J. T. Prostaglandin synthase-dependent benzo(a)pyrene oxidation products of the oxidation and inhibition of their formation by annoxidants. Biochem. Biophys. Res. Commun., 79: 569-576, 1977.
54. Gelboin, H. V Benzo[a]pyrene metabolism, activation, and carcinogenesis, role and regulation of mixed function oxidases and related enzymes. Physiol. Rev., 60: 1107-1166, 1980.
55. Eling, T. E., Thompson, D. C., Foureman, G L., Curtis, J. F , and Hughs, M. F Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol. Toxicol., 30: 1-45, 1990.
56. Winn, L. M., and Wells, P. G Free radical mediated mechanisms of anticonvulsant teratogenicity. Eur. J. Neurol., 2 (Suppl. 4). 5-29, 1995.